Newsroom Archive

2019

HHS Secretary Azar Statement on FDA Approval of Ebola Vaccine

19 December 2019

HHS Supports Advanced Development for Treatment of Anthrax Lung Infections

18 December 2019

HHS Invests in Modernizing U.S. Manufacturing Capacity for Pandemic Influenza Vaccine; Sanofi Pasteur

09 December 2019

HHS Advances Development of Tests to Distinguish Bacterial from Viral Infections across Multiple Healthcare Settings

14 November 2019

HHS to advance development of Cytovale rapid sepsis diagnostic

30 October 2019

HHS joins forces on machine-learning algorithm to identify Sepsis

29 October 2019

FDA allows marketing of first rapid diagnostic test for detecting Ebola virus antigens

10 October 2019

BARDA Industry Day Lightning Talk Selectees

09 October 2019

HHS Explores Lung-on-a-Chip Technology in Developing Chemical Injury Treatments

08 October 2019

HHS Funds Development of Two Filovirus Vaccines for Biodefense, Public Health

01 October 2019

HHS advances novel technology to meet need for blood platelets in a nuclear disaster

30 September 2019

Newly FDA-Licensed Vaccine for the Prevention of Smallpox & Monkeypox Marks Major Milestone in Domestic & Global Health Security

24 September 2019

HHS Provides Expertise, $14 Million to Advance Development of Investigational Ebola Treatment

20 September 2019

HHS expands network of innovation accelerators to transform

16 September 2019

HHS Purchases Smallpox Vaccine to Enhance Biodefense Preparedness

03 September 2019

BARDA Industry Day Lightning Talks

12 August 2019

HHS, DoD, VenatoRx Pharmaceuticals to co-develop novel antibiotic to treat drug-resistant infections

22 July 2019

First medical product cleared in U.S. for use on certain injuries caused by sulfur mustard

22 July 2019

HHS sponsors development of portable, user-friendly burn imaging device

18 July 2019

HHS Seeks to Expand its Network Innovation Accelerators into More States

29 May 2019

HHS’ BARDA funds its first Marburg virus vaccine development

29 May 2019

New HHS-Sponsored Research Provides New Tool and Updated Guidance on Mass Chemical Decontamination

21 February 2019

2018

HHS expands corporate partnership to protect against health security threats

10 October 2018

HHS seeks to repurpose burn dressings for radiation emergencies

02 October 2018

HHS, Genentech join forces on medicines to combat influenza, other health security threats

01 October 2018

HHS sponsors new formulation of world’s first approved smallpox drug

25 September 2018

HHS enlists MediWound to develop treatment for sulfur mustard injury

24 September 2018

HHS partners to develop faster tests to identify bacterial infections

18 September 2018

BARDA Industry Day Lightning Talks

18 August 2018

HHS, DoD, Spero co-sponsor novel oral antibiotic development to treat deadly infections

16 July 2018

Statement by Rick Bright, PhD, Director of ASPR’s Biomedical Advanced Research and Development Authority on the recent FDA approval of TPOXX® as a treatment for smallpox

13 July 2018

At-home influenza tests take leap forward

11 July 2018

BARDA Industry Day 2018: Save the Date

03 July 2018

Philadelphia company selected to accelerate innovation for U.S. health security, daily medical care

05 June 2018

Houston company selected to accelerate innovation for U.S. health security, daily medical care

05 June 2018

New York Tristate Area company selected to accelerate innovation for U.S. health security, daily medical care

05 June 2018

New Orleans company selected to accelerate innovation for U.S. health security, daily medical care

05 June 2018

Los Angeles company selected to accelerate innovation for U.S. health security, daily medical care

05 June 2018

Greater Boston company selected to accelerate innovation for U.S. health security, daily medical care

05 June 2018

Raleigh-Durham company selected to accelerate innovation for U.S. health security, daily medical care

05 June 2018

Seattle-Bellevue company selected to accelerate innovation for U.S. health security, daily medical care

05 June 2018

HHS partners to develop new treatment for seizures caused by nerve agents

27 April 2018

BARDA has purchased anthrax antitoxin from Elusys Therapeutics Inc., for the Strategic National Stockpile as part of an integrated, portfolio approach to protecting Americans from 21st century health security threats.

23 April 2018

New BARDA Funding Opportunity Announcement: BARDA Division of Research, Innovation and Ventures (DRIVe) Accelerator Network

18 April 2018

New Requests for Information posted: ENACT and Solving Sepsis

17 April 2018

Decontamination Decoded: Disrobing, Dry Wiping Removes 99% of Chemical Contaminants

11 April 2018

FDA approves Leukine for Acute Radiation Syndrome

29 March 2018

2017

BARDA Supports a Rapid, Deployable, Sensitive Diagnostic Platform to Diagnose Anthrax

20 November 2017

Now Open: BARDA Broad Agency Announcement - Advanced Research and Development of Medical Countermeasures for Pandemic Influenza, Infectious Diseases, and Chemical, Biological, Radiological and Nuclear Threats

06 November 2017

CARB-X awards Amicrobe $2.48M to accelerate the development of Amicidin-β topical antimicrobial

24 October 2017

HHS sponsors development of drug to treat infections from biowarfare agents, antibiotic-resistant bacteria

06 October 2017

HHS pursues therapeutic for radiation injury affecting blood platelets

06 October 2017

HHS, Regeneron partner on portfolio of treatments for pandemic influenza, emerging infectious diseases

03 October 2017

HHS sponsors development of two tests for radiation exposure

03 October 2017

HHS pursues reusable respirator to better protect medical providers during pandemics

02 October 2017

HHS accelerates development of first Ebola vaccines and drugs

29 September 2017

HHS boosts biodefense preparedness with smallpox vaccine for special populations

28 September 2017

HHS leverages potential respiratory drug as chemical weapon antidote

27 September 2017

HHS advances point-of-care diagnostic test for anthrax

26 September 2017

HHS partners to develop first intranasal treatment for cyanide poisoning

18 September 2017

HHS, Janssen Research & Development join forces on innovative influenza products

15 September 2017

HHS spurs new antibiotic development for biodefense and common infections

11 September 2017

BARDA adds new antibiotic to treat drug-resistant bacterial infections in order to protect the American public

30 August 2017

CARB-X announces funding for global scientists racing to discover new antibiotics to treat superbugs

25 July 2017

RFP: Radiation Biodosimetry Point of Care Biodosimetry Tests

16 June 2017

RFP: Radiation Biodosimetry Biodosimetry High Throughput Tests

16 June 2017

Pre-Solicitation of a Radiation Biodosimetry High Throughput Test

01 June 2017

Pre-Solicitation of a Radiation Biodosimetry Point of Care Test

01 June 2017

HHS sponsors new Zika diagnostic test, boosting national testing capacity

12 April 2017

CARB-X injects up to $48 million to accelerate first Powered by CARB-X portfolio of drug discovery and development projects to tackle antibiotic resistance

30 March 2017

Antimicrobial Resistance Diagnostic Challenge selects 10 semifinalists in first phase of competition

27 March 2017

2016

Assistant Secretary Nicole Lurie announces new BARDA Director

11 November 2016

HHS enhances nation’s health preparedness for radiological threats

06 October 2016

HHS pursues tests for radiation absorbed in nuclear emergency

05 October 2016

HHS sponsors commercial manufacturing tests for Ebola vaccine

04 October 2016

HHS sponsors next-generation genetic sequencing platform

30 September 2016

HHS supports next-generation anthrax vaccine into advanced development

30 September 2016

For bioterrorism preparedness, HHS sponsors inhaled chlorine antidote

29 September 2016

BARDA awards funding to speed development of Zika vaccine

26 September 2016

HHS forges strategic partnerships with two global companies to develop new antibiotics

21 September 2016

Federal prize competition seeks innovative ideas to combat antimicrobial resistance

08 September 2016

HHS accelerates development of mRNA-based Zika vaccine

07 September 2016

HHS awards $ 19.8 million to Japanese company to accelerate development of a Zika vaccine

01 September 2016

HHS funds development of Zika diagnostic test for use in doctors’ offices

25 August 2016

HHS awards $7 million to OraSure to speed development of Zika diagnostic test

23 August 2016

HHS awards $2.6 million to DiaSorin Group to develop rapid, high-capacity Zika diagnostic laboratory test

22 August 2016

HHS declares a public health emergency in Puerto Rico in response to Zika outbreak

12 August 2016

HHS awards $5.1 million to InBios to advance Zika diagnostic

01 August 2016

Single-dose anthrax vaccine enters clinical trial with HHS support

01 August 2016

HHS forges unprecedented partnership to combat antimicrobial resistance

28 July 2016

HHS calls on center for innovation to accelerate Zika vaccine development

27 June 2016

HHS moves to boost Zika vaccine capacity in Brazil

24 June 2016

HHS advances pathogen reduction technologies for blood products

20 June 2016

HHS selects regional Ebola treatment center for southwestern U.S.

14 June 2016

HHS-sponsored study shows disrobing is vital decontamination method

10 May 2016

HHS pursues development of single dose nasal spray anthrax vaccine

10 May 2016

HHS sponsors point-of-care anthrax diagnostic test

09 May 2016

HHS helping lift key hurdle in the efforts to develop better Zika diagnostics

27 April 2016

HHS sponsors new broad spectrum antibiotic development

20 April 2016

HHS ships blood products to Puerto Rico in response to Zika outbreak

07 March 2016

BARDA seeks to launch a novel partnership, a product accelerator to address antimicrobial Resistance

19 February 2016

Pre-Solicitation for the Advanced Development of Medical Countermeasures for Biological Animal Model Development

08 January 2016

2015

HHS Funds Development of High-Speed Manufacturing for N95 Respirators

10 December 2015

Request for Feedback of Draft RFP for Respiratory Illness Live Virus Fill/Finish Services

20 November 2015

Sources Sought Notice for Respiratory Illness Live Virus Fill / Finish Services

20 November 2015

HHS to procure two inhalational anthrax treatments for national supply

12 November 2015

Now Open: Broad Agency Announcements for Advanced Research and Development of Medical Countermeasures for Pandemic Influenza, Infectious Diseases, and Chemical, Biological, Radiological and Nuclear Threats

13 October 2015

Pre-Solicitation: Broad Agency Announcement (BAA) for the Advanced Development of Medical Countermeasures for Pandemic Influenza

01 October 2015

Coming Soon: Broad Agency Announcements for Advanced Research and Development of Medical Countermeasures for Pandemic Influenza, Infectious Diseases, and Chemical, Biological, Radiological and Nuclear Threats

01 October 2015

BARDA Sponsors Development of New Skin Substitute to Treat Large Burns

01 October 2015

HHS enhances preparedness with new products to treat severe burns

30 September 2015

HHS sponsors innovative approaches to improve influenza vaccines

30 September 2015

HHS advances development of novel drug to treat influenza

29 September 2015

HHS sponsors development of drug for hospitalized influenza Patients

28 September 2015

HHS explores new disaster use of approved “clot busting” drug

23 September 2015

HHS advances development of new monoclonal antibody drug for Ebola

21 September 2015

HHS enters into strategic alliance to accelerate new antibiotic development

16 September 2015

Experimental Ebola vaccine regimen takes new steps under HHS program

14 September 2015

Development of new anthrax vaccine underway with HHS support

17 August 2015

RFP for Advanced Development of Broad-Spectrum Influenza Monoclonal Antibodies

06 August 2015

HHS partnership advances experimental Ebola drug

20 July 2015

Advanced Development of Broad-Spectrum Influenza Monoclonal Antibodies Request For Proposals (RFP)

19 May 2015

FDA/CDER-BARDA Innovations in Medical Countermeasure Continuous Manufacturing Request for Information

21 April 2015

BARDA Chem and RadNuc Animal Model Development RFP

06 April 2015

HHS seeks to develop improved anthrax vaccine

23 March 2015

Advanced Development of More Effective/Universal Influenza Vaccines Request for Proposals (RFP)

16 March 2015

ASPR/BARDA Contract Research Organizations for Nonclinical Studies (BIO) Solicitation

11 March 2015

ASPR/BARDA Contract Research Organizations for Nonclinical Studies (BIO) - Other Than Small Business Sources Sought Notice

11 March 2015

The 2014 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Strategy and Implementation Plan (SIP)

24 February 2015

2014

HHS supports efforts to speed Ebola vaccine delivery

23 December 2014

BARDA Chem and RadNuc Animal Model Development

05 December 2014

HHS advances development of Ebola vaccine

16 October 2014

HHS pursues detection tests for influenza

01 October 2014

HHS funds drug to treat severe infections and prevent cytokine storm

29 September 2014

HHS spurs innovation to develop next-generation portable ventilator

17 September 2014

HHS contracts with Mapp Biopharmaceutical to develop Ebola drug

02 September 2014

Ebola Experimental Treatments & Vaccines FAQ

06 August 2014

A Justification for Other than Full and Open Competition (JOFOC) for the use of Vaxin to solicit: "A new Request for Task Order Response (RTOR) for the continued development Vaxin's Ad5 Vectored Anthrax vaccine candidate via the HHS CIADM program

09 July 2014

BARDA Funding Opportunity Announcement: Establish Adjuvant Hub to Enable Adjuvanted Influenza Vaccines in Under-Resourced Nations

07 July 2014

A Justification for Other than Full and Open Competition for the use of Pfenex Inc. to solicit: "A new RTOR for the continued development of the Pfenex Expression Technology™ for an anthrax vaccine via the HHS CIADM program"

02 July 2014

BARDA Industry Day Conference 2014 - Registration Now Open

30 June 2014

Amendments to Broad Agency Announcements for Advanced Research and Development of Medical Countermeasures for Pandemic Influenza and Chemical, Biological, Radiological and Nuclear Threats

26 June 2014

HHS establishes new network to perform clinical studies

11 March 2014

HHS funds drug for bioterrorism, antimicrobial-resistant infections

05 February 2014

2013

HHS fosters development of new blood test for anthrax

21 October 2013

HHS boosts national capacity to produce pandemic flu vaccine

30 September 2013

HHS boosts stockpile of products to treat acute radiation syndrome

26 September 2013

HHS pursues nerve agent anti-seizure drug for children and adults

25 September 2013

HHS replenishes nation’s supply of anthrax antitoxin

19 September 2013

BARDA funds study of therapy for thermal burns

17 September 2013

BARDA evaluates burn dressing for radiation, sulfur mustard burns

16 September 2013

BARDA Contract Supports Evaluation of Therapy for Severe Thermal Burns

23 August 2013

BARDA Supports Proof-Of-Concept Studies for Small Molecule Development

22 August 2013

BARDA Solicits Research Efforts for Innovative Technologies to Improve Public Health Emergency Preparedness

01 August 2013

Register for the BARDA Broad Agency Announcement (BAA) Pre-Proposal Conference

01 August 2013

UPDATED: Broad Agency Announcements for Advanced Research and Development of Medical Countermeasures for Pandemic Influenza and Chemical, Biological, Radiological and Nuclear Threats

31 July 2013

2012 BioShield Annual Report to Congress

18 July 2013

Drug could be first against two bioterrorism threats as well as common drug-resistant infections

16 July 2013

Pre-Solicitation Notice for Science and Technology Platforms Applied to Medical Countermeasure Development (Innovations) for BARDA

16 July 2013

Pre-Solicitation Notice for the Advancement of Medical Countermeasures for Pandemic Influenza

16 July 2013

BARDA Supports New Broad-Spectrum Antibiotic Drug

25 June 2013

BARDA issues Request for Proposals for Public Health and Medical Consequence Modeling Network

05 June 2013

HHS Forms Strategic Alliance to Develop New Antibiotics

22 May 2013

Pre-solicitation Notice for Ancillary Acquisition to Support Pandemic Influenza Preparedness

13 May 2013

HHS awards contract to create test to identify resistant influenza viruses

03 April 2013

Medical Countermeasures Clinical Studies Network RFP

01 April 2013

FDA Approval of Botulism Antitoxin Heptavalent

22 March 2013

FDA approval of Botulism Antitoxin Heptavalent, statement from HHS Assistant Secretary for Preparedness and Response Dr. Nicole Lurie

22 March 2013

Smart DME/Power Generation RFI

18 March 2013

Request for Information Posted: Agents and/or Approaches for Treatment of New and Emerging Infectious Threats

18 March 2013

Pandemic and All Hazards Preparedness Reauthorization Act

13 March 2013

HHS Awards Contract for Advanced Development of Novel Flu Treatment

28 February 2013

BARDA Fill-Finish Manufacturing Network Solicitation posted

08 February 2013

BARDA Fill-Finish Manufacturing Network synopsis posted

23 January 2013

Statement from Assistant Secretary Nicole Lurie on FDA approval of new influenza vaccine manufactured with novel technology

17 January 2013

FDA approves new seasonal influenza vaccine

16 January 2013

Website Refresh - www.medicalcountermeasures.gov is pleased to announce a phased launch of our newly redesigned public website. We are making website improvements to provide a more modern and customer-centric web experience. Over the next several months you will see differences throughout the site while we continue implementing updates. Thank you for your understanding and please let us know if you have any questions: techwatchinbox@hhs.gov